Zai Lab Limited (ZLAB) has a profit margin of -41.86%, below the Healthcare sector average of 13.89%.
Get informed when a big investor buys or sells
+ FollowAs of Jun 2026
Trailing 12 months ending Jun 2026
Zai Lab Limited (ZLAB) currently reports a profit margin of -41.86% as of June 2026. That compares with -49.68% in the prior-year period — up 15.7% year over year. That is below the Healthcare sector average of 13.89%. Use the charts on this page to explore Zai Lab Limited's profit margin history and peer comparisons.
Zai Lab Limited's profit margin increased from -49.68% to -41.86% — a 15.7% year-over-year increase (period ending June 2026). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.
Zai Lab Limited's profit margin of -41.86% is lower than the Healthcare sector average of 13.89%. That is roughly 401.3% below the sector mean. A reading lower peers can reflect different growth expectations, capital structure, or profitability — so it is worth checking the peer comparison chart before drawing conclusions.
There is no universal 'good' profit margin, but Zai Lab Limited's current -41.86% should be judged against Healthcare norms (sector average: 13.89%) and against ZLAB's own history. Strong, stable readings often indicate durable competitive advantage; volatile or declining ones deserve a closer look at margins and capital efficiency.
Start with the current profit margin of -41.86%, then check the historical chart for trend and the peer comparison chart for relative positioning. The Healthcare average is 13.89%. From there, open related valuation or income-statement pages for Zai Lab Limited, and consider following ZLAB for alerts when major investors trade the stock.